Neopharm Inactive 10-Q2002 Q3 Quarterly report

Filed: 14 Aug 02, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: achieved, alleging, America, announced, announcement, anticipate, anticipated, Antisense, ARTICLE, Certificate, chemotherapy, clarify, combined, Committee, comprised, counter, counterclaim, craf, created, Delaware, denying, designated, designed, determine, determined, employee, enrollment, Equity, equivalent, Exhibit, experienced, exposed, glioblastoma, half, Incentive, Incorporation, IND, issuance, KPMG, legal, LEM, LErafAON, liability, mesothelioma, million, Mitoxantrone, multiforme, obtain, Oligonucleotide, outcome, ovarian, Oxley, patent, patient, performance, Plan, precision, predict, preferred, previously, principal, projected, prostate, punitive, pursue, radiation, range, recommendation, reduce, reduction, reimbursement, renew, resistant, resolution, responded, response, Restated, restitution, Secretary, shareholder, significant, state, submitted, subsequent, subsequently, toxin, unable, unnecessary

Removed: applicable, Forest, Lake, statement

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Neopharm similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 99.1

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(SUBSECTIONS (a) AND (b) OF SECTION 1350, CHAPTER 63 OF TITLE 18,

UNITED STATES CODE)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of Title 18, United States Code), each of the undersigned officers of NeoPharm, Inc., a Delaware corporation (the “Company”), does hereby certify with respect to the Quarterly Report of the Company on Form 10-Q for the quarter ended June 30, 2002 as filed with the Securities and Exchange Commission (the “10-Q Report”) that:

(1) the 10-Q Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the 10-Q Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: August 14, 2002		/s/ James M. Hussey
		James M. Hussey,
		Chief Executive Officer

Dated: August 14, 2002		/s/ Lawrence A. Kenyon
		Lawrence A. Kenyon,
		Chief Financial Officer

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.